Comparing Two Blood Pressure Medicines After Childbirth in Women With Hypertension
Compares nifedipine and enalapril for high blood pressure in women after giving birth.
Key facts
- Who runs it
- Nebraska Methodist Health System
- Where
- Omaha, United StatesSee the site
- Trial code
- Registry title
- Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 850 people, planned
- Started
- 11 Jul 2025
- Expected to end
- Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Enalapril 10mg QD
- Nifedipine 30mg XL BID
- Record updated
- 22 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women admitted to give birth with high blood pressure, either long-standing or related to pregnancy. It compares two blood pressure medicines after delivery.
- Age
- 19 years or older
- Sex
- Women only
- Disease stage
- High blood pressure from pregnancy or long-standing high blood pressure, at 24 weeks of pregnancy or more at delivery
- Biomarker or test result
- Pregnancy-related high blood pressure means a systolic pressure of 140 mmHg or more, or a diastolic pressure of 90 mmHg or more, on two occasions at least 4 hours apart
Main reasons for not taking part
- Cannot take nifedipine or enalapril for medical reasons
- Heart rate that stays below 60 or above 110
- Native language other than English
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- admitted for delivery by cesarean or vaginal delivery
- 24 weeks gestation or greater
- Pregnancy related hypertension(HTN) or chronic hypertension. Pregnancy related hypertension will be defined during the study as either a systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg on two occasions at least 4 hours apart. This definition is consistent with the ACOG definition for pregnancy related HTN in patients without CHTN
Who cannot take part
- Absolute contraindication to either nifedipine or enalapril Relative contraindications will be reviewed with PI
- Persistent HR <60 or >110
- Native language other than English
Where in United States
- Methodist Women's HospitalOmaha, United StatesContact: Todd LovgrenTaking people
About the trial
What the trial wants to find out
This is an open label, randomized controlled trial designed to compare nifedipine and enalapril in the management of postpartum hypertension. This is an equivalence study- meaning it is not expected one medication is better than the other. Nifedipine has been shown to be better than another common blood pressure medicine, labetalol, for postpartum hypertension but enalapril which is also used worldwide to manage blood pressure postpartum, has not yet been evaluated or compared to nifedipine.
Read full original descriptionShow less
Investigators will identify and offer enrollment to women who are admitted for delivery with documented hypertension- participants with either chronic hypertension or pregnancy related hypertension will be included. Our hypothesis is both medications are safe and effective in managing blood pressure and preventing readmission for hypertensive complications during the postpartum period so evaluating the rate of readmission is the primary goal of the study.
The only intervention of the trial will be to assign which medication the participant starts taking. Any decisions after that point- stopping medication, changing doses, additional medications, discharge from the hospital, etc, will all be at the discretion of the participant's primary provider.
The 2 groups in the trial
- Nifedipine XRExisting treatment, for comparison
Patients will be randomized to receive nifedipine 30mg XR BID. Any additional changes in treatment will be at the discretion of their provider.
Treatment: Nifedipine 30mg XL BID
- Enalapril 10mg QDTreatment being tested
Patients will be administered 10mg enalapril daily. Any additional intervention or changes in management of their hypertension will be at the discretion of their primary provider.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Postpartum Evaluation of Antihypertensives for Control of Hypertension: A Randomized Controlled Equivalence Study
- Plain-language title
- Comparing Two Blood Pressure Medicines After Childbirth in Women With HypertensionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 October 2025